Stifel Upgrades Staar Surgical to Buy, Raises Price Target to $31

Stifel analyst Thomas Stephan has upgraded Staar Surgical (NASDAQ: STAA) from a Hold to a Buy rating. The price target for the stock has been increased from $28 to $31.